ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Milano, Lombardia

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Disease
Lung Diseases
Rhinitis
Chronic Obstructive Pulmonary Disease
Dust Mite Allergy

Asthma trials near Milano, Lombardia, ITA:

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

The objective of this study is to assess the potential for GB-0895 to improve the health of adolescents and adults with severe asthma that i...

Enrolling
Severe Asthma
Drug: GB-0895
Drug: Placebo

Phase 3

Generate Biomedicines

Brescia, Lombardy, Italy and 130 other locations

study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...

Active, not recruiting
Asthma
Other: Spirometry
Drug: Mepolizumab

Phase 4

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Rozzano, Italy and 65 other locations

Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and wor...

Enrolling
Asthma
Biological: Depemokimab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Rozzano, Italy and 49 other locations

To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...

Enrolling
Asthma
Biological: Tezepelumab
Other: Placebo

Phase 3

AstraZeneca
AstraZeneca

Pavia, Italy and 146 other locations

to budesonide in children from 6 to less than 12 years of age with asthma.* The study duration will be up to 37 weeks including an investiga...

Enrolling
Asthma
Drug: QMF149
Drug: Budesonide

Phase 3

Novartis
Novartis

Pavia, PV, Italy and 64 other locations

PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, ...

Enrolling
Asthma
Other: Placebo
Drug: PF-07275315

Phase 2

Pfizer
Pfizer

Rozzano, MILANO, Italy and 136 other locations

This study evaluates the efficacy and safety of benralizumab as an add-on therapy in uncontrolled eosinophilic asthma participants treated w...

Enrolling
Eosinophilic Asthma
Combination Product: Placebo for Benralizumab
Combination Product: benralizumab

Phase 3

AstraZeneca
AstraZeneca

Milan, Italy and 166 other locations

treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...

Invitation-only
Asthma
Wheezing
Drug: Placebo
Drug: Dupilumab

Phase 3

Sanofi
Sanofi

Milan, Lombardy, Italy and 74 other locations

experimental drug called CHF5993 pMDI compared to the currently approved Seretide 125 Evohaler pMDI in adolescent patients with uncontrolled asthma...

Begins enrollment in 1 month
Asthma
Drug: Seretide Evohaler
Drug: CHF5993 100/6/12.5 μg pMDI HFA-152a

Phase 3

Chiesi
Chiesi

Milan, Italy and 24 other locations

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this...

Active, not recruiting
Asthma
Drug: Budesonide/Albuterol
Drug: Lunsekimig

Phase 2

Sanofi
Sanofi

Milan, Milano, Italy and 230 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems